Navari, R. M., Ruddy, K. J., LeBlanc, T. W., Clark-Snow, R. A., Wickham, R. S., Binder, G., … Roeland, E. (2019). Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC >= 4. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 37). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.

Navari, Rudolph M., Kathryn Jean Ruddy, Thomas William LeBlanc, Rebecca Anne Clark-Snow, Rita S. Wickham, Gary Binder, Tammy Bratton Coberly, Ravi C. Potluri, Luke M. Schmerold, and Eric Roeland. “Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC >= 4.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 37. AMER SOC CLINICAL ONCOLOGY, 2019.

Navari RM, Ruddy KJ, LeBlanc TW, Clark-Snow RA, Wickham RS, Binder G, et al. Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC >= 4. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2019.

Navari, Rudolph M., et al. “Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC >= 4.” JOURNAL OF CLINICAL ONCOLOGY, vol. 37, no. 15, AMER SOC CLINICAL ONCOLOGY, 2019.

Navari RM, Ruddy KJ, LeBlanc TW, Clark-Snow RA, Wickham RS, Binder G, Coberly TB, Potluri RC, Schmerold LM, Roeland E. Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC >= 4. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2019.